ÐÏࡱá>þÿ 79þÿÿÿ6ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥ÁÀ ð¿Ybjbj¢¢ 4"rÈrÈY ÿÿÿÿÿÿ·Ø Ø 22222ÿÿÿÿFFFFbF!>~~~~~YYY„ † † † † † † $C#²õ%Bª 2YYYYYª 22~~Û¿ ½½½Y:2~2~„ ½Y„ ½½:p,Ô~ÿÿÿÿ@«·¾V”Ïÿÿÿÿ“œ p Õ 0!¦.7&© 7&Ô7&2ÔœYY½YYYYYª ª ³ YYY!YYYYÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ7&YYYYYYYYYØ ø: CLINICAL PHARMACOLOGY (SEPTEMBER START) (MSc/PgDip/PgCert) 57B200BT/61B200BT/61B200X5/62B200VZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Medicine, Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biology, Biomedical Science). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time (PgDip) Aim: To equip students for careers developing and expanding current knowledge of drugs and their use in man. To achieve this, the programme provides a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical assessment and clinical trials; and regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and directed self-learning. The curriculum includes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; aspects of drug development; therapeutics; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. Candidates shall be required to attend the following designated programme of courses: Stage 1 GS50M1 Generic Skills (0 credit points) MT5003 Drug Metabolism and Toxicology (15 credit points) MT5027 Therapeutics (15 credit points) MT5010 Induction Course (5 credit points) MT5024 Molecular Pharmacology (10 credit points) PU5017 Applied Statistics (15 credit points) Above courses contribute to degree award with the addition of one of the following courses are available as additional credits MB5022 Introduction to Molecular Biology (15 credit points) Stage 2 BT5902 Laboratory Techniques – Core Practical Skills (15 credit points) MT5501 Pharmacovigilance (5 credit points) MT5502 Drug Development to Evidence Based Medicine (20 credit points) MT5503 Pharmacokinetics (10 credit points) MT5515 Basic Research Methods (15 credit points) Above courses contribute to degree award. The following course is available as additional credits BT 5506 Business of Science (5 credit points) Diploma candidates may be allowed to transfer to the MSc if they complete the above programme at an appropriate standard. No candidate will be allowed to progress to Stage 3 as an MSc candidate if they fail to achieve an appropriate standard in stages 1 and 2 of the programme. MSc candidates with a registered medical qualification may be able to carry out a clinical research project in the final stage under supervision of one of the medical staff. Stage 3 MT5903 Research Project (60 credit points) Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The project will be assessed on the basis of performance, written thesis, and oral presentation. There will usually be an oral examination to complete the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. &l†= G • – œ í    + , ¢ ­ Û ä æ > E « ® ¾ ¿ Ó Õ ù ÿ .0FGWXóéóÛóÛóÍ¿²¨²¨²¨²¨²¿²óš�ƒ�ƒ�y�o�o�y�y�šhÝKèOJQJaJh3?òOJQJaJhëOJQJaJh…x;h3?òOJQJaJh…x;h3?ò>*°¿´³²Ï´³²¹´³³ó¿~±á°¿´³²Ï´³²¹´³³ó¾³ó¿~±á°¿´³²Ï´³²¹´³³ó¾³ó¿~±á6�O´³²Ï´³²¹´³³ó…x;³ó…x;5�O´³²Ï´³²¹´³³ó…x;³ó…x;6�O´³²Ï´³²¹´³³ó±¹�°¿´³²Ï´³²¹´³³ó…x;³ó…x;°¿´³²Ï´³²¹´³&¹ó°ì±ô< = • – Ú Û æ ç = > F G o ¨ Ï ù óçÞÔÇÔÔ½½½ÇÔÔ³³©©©© Æ„gd3?ò Æ0gd3?ò Æ0gd¿~H $ Æ0a$gd…x; Æ0gd…x;  Æ9r gd…x;  ÆD%dðgd…x;  Æ6$dðgd…x;ù *WXØÙg“Ù56™šÉÊ�õõéõéééÙÍõõõõõõõõÄ·­ Æ0gd¿~H $ Æ0a$gd…x; Æ„gd3?ò Æ 0*gd3?ò Æ 0*¤¤gd3?ò Æ 0„gd3?ò Æ„gd3?òX€«ÎÏרÙßà$%UVWXfg46_`uw��˜šÉÊÀñæñÛñÛÍööͣ¶–Œ¶–Œ–¶Ã¶Ã‚öñÛñæñÛñÛ¶uhh¾h¿~HOJQJaJh…x;h…x;OJQJaJhv�OJQJaJh'dþOJQJaJh…x;h'dþOJQJaJ%h…x;h3?ò5�6�>*CJOJQJaJh…x;h3?òOJQJaJh3?òOJQJaJh…x;h3?ò>*OJQJaJh3?ò6�OJQJaJh¿~H6�OJQJaJhÐhh3?ò6�OJQJaJ&ÀÎÏÖ�‘˜š›ž¡´µÈÔp¶ßêWXYöéöéÜÎÁ³Á©Á©Á›éöéöéŒ}h…x;hÇv‘OJQJ^JaJh¾h¿~HOJQJ^JaJh¾h¿~H6�OJQJaJhÇv‘OJQJaJh…x;hÇv‘6�OJQJaJh…x;hÇv‘OJQJaJh…x;hÇv‘>*OJQJaJh…x;h…x;OJQJaJh¾h¿~HOJQJaJh¿~HOJQJaJ�‘™šÇÈXYõëëÛÏÅÅ Æ0gd¿~H  Æ 9r 0gdÇv‘ Æ 0„„˜þ`„˜þgdÇv‘ Æ0gdÇv‘ Æ0gd…x;21�h:p[=°‚. °ÆA!° "° #� $� %°°Ä°Ä �Äj ˜žžžžžžž666666666vvvvvvvvv66666>666666666666666666666666666¨6666666666¸6666666666hH66666666666666666666666666666666666666666666666666666666666666666°62ÀÐàð 0@P`p€�ÀÐàð2(Øè 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�8XøV~ OJPJQJ_HmH nH sH tH N`ñÿN ° Normal$a$ CJOJPJQJ_HmH sH tH `@` „+´� Heading 2$¤ð¤<@&$5�6�CJOJPJQJ\�]�^JaJ>@> °  Heading 3$d8ÿ@&5�X@X î=� Heading 6 ¤ð¤<@&5�CJOJPJQJ\�^JaJR@R "2^� Heading 7 ¤ð¤<@&CJOJPJQJ^JaJX@X N$Ð� Heading 8 ¤ð¤<@&6�CJOJPJQJ]�^JaJDA òÿ¡D Default Paragraph FontRióÿ³R 0 Table Normalö4Ö l4Öaö (k ôÿÁ( 0No List PþoòÿñP ° Heading 3 Char5CJOJPJQJ^JaJ\þoòÿ\ „+´�Heading 2 Char(56CJOJPJQJ\]^JaJtH 4@4 „+´Header  Æ9r Bþoòÿ!B „+´ Header CharCJOJPJQJtH Vþoòÿ1V î=�Heading 6 Char"5CJOJPJQJ\^JaJtH PþoòÿAP "2^�Heading 7 CharCJOJPJQJ^JaJtH JZ@RJ w�0 Plain Text$a$CJOJQJ^JtH FþoòÿaF w�0Plain Text CharOJPJQJ^JVQ@rV ft Body Text 3$ Æ0d6ÿa$ 5�OJQJPþoòÿ�P ftBody Text 3 Char5CJOJPJQJtH Vþoòÿ‘V N$Ð�Heading 8 Char"6CJOJPJQJ]^JaJtH 6U`òÿ¡6 mOÛ Hyperlink >*B*phÿPK!éÞ¿ÿ[Content_Types].xml¬‘ËNÃ0E÷Hüƒå-Jœ²@%é‚ÇŽÇ¢|ÀÈ™$ÉØ²§Uû÷LÒTB¨ l,Ù3÷ž;ãr½µÃ˜œ§J¯òB+$ëG]¥ß7OÙ­V‰�$ùãûÿ©«×îÇ !)OÚ^ýrÍC$ñy@“°íÝö/­yH*œ˜ñ„´½)‘Þµ�÷ß»Š×UDb‚`}"×qÛ‹”J×—–¤ÃX^æ)I`nÌEŒ¼Šp)øèÆli¹V[]Š1M<”àÈÞ�©OÐP“ô6râ=¯‰’zÀgb Ig…Áu��SÙebÖö€OÀ�†ä¾òÃRÁDÛ«™Ÿ·´qu ¯g‹˜Z°¶´®o~ÙºlAp°lxŠpT0­÷­+[}`j×ëõº½zAϰV–2ÍF­ÞÉi–@öqžv·Ö¬5\|‰þʜ̭N§Óle²X¢dsøµÚjcsÙÁ�Å7çð�Îf·»êà ÈâWçðý+­Õ†‹7 ˆÑä`­ÚïgÔ È˜³íJøÀ×j|†‚h(¢K³óD-еß㢠dXÑ©iJÆØ‡(îâx$(Ö ð:Á¥;ä˹!Í I_ÐTµ½S 1£÷êù÷¯ž?EÇž?øéøáÃã?ZBΪmœ„åU/¿ýìÏÇ£?ž~óòÑÕxYÆÿúÃ'¿üüy5Òg&΋/ŸüöìÉ‹¯>ýý»GðM�Geø�ÆD¢›äíó3Vq%'#q¾ÃÓòŠÍ$”8ÁšKýžŠôÍ)f™w9:ĵàå£ x}rÏx‰‰¢œw¢ØîrÎ:\TZaGó*™y8IÂjæbRÆíc|XÅ»‹Ç¿½I u3KGñnD1÷NIBÒsü€� íîRêØu—ú‚K>Vè.EL+M2¤#'šf‹¶i ~™Vé þvl³{u8«Òz‹ºHÈ Ì*„æ˜ñ:ž(W‘☕ ~«¨JÈÁTøe\O*ðtHG½€HYµæ–}KNßÁP±*ݾ˦±‹ŠTѼ�9/#·øA7ÂqZ…Ð$*c?�¢íqUßån†èwðNºû%Ž»O¯·ièˆ4 =3¾¼N¸¿ƒ)cbJ u§VÇ4ù»ÂÍ(TnËáâ 7”Ê_?®�ûm-Ù›°{UåÌö‰B½w²ÒzÏû¨nœ”ÇÊœ"Z úàxŠÕJÜZšìp;‹“Êì ØåÞ{/å<óP;™Ž,)''KÐQÛk5—›òqÚöÆpN†Ç8¯KÝGbÂe“¯„ ûS“ÙdùÌ›­\17 êpõaí>§°SR!Õ–‘ 3•…K4'+ÿrÌzQ TT£³I±²Áð¯Ivt]KÆc⫲³K#Úvö5+¥|¢ˆDÁ±‰ØÇà~ª O@%\w˜Š _ànN[ÛL¹Å9Kºò�˜ÁÙqÌÒgåV§hžÉn R!ƒy+‰ºUÊn”;¿*&å/H•rÿÏTÑû Ü>¬Ú>\ Œt¦´=.TÄ¡ ¥õûS; Zà~¦!¨à‚ÚüäPÿ·9gi˜´†C¤Ú§!ö# Bö ,™è;…X=Û»,I–2UW¦Vì9$l¨kàªÞÛ=A¨›j’•ƒ;î{–A£P79å|s*Y±÷Úø§;›Ì ”[‡MC“Û¿±hf»ª]o–ç{oY=1k³yV³ÒVÐÊÒþ5E8çVk+ÖœÆËÍ\8ðâ¼Æ0X4D)Ü!!ýö?*|f¿vè uÈ÷¡¶"øx¡‰AØ@T_²�ÒÒŽ q²ƒ6˜4)kÚ¬uÒVË7ë ît ¾'Œ­%;‹¿Ïiì¢9sÙ9¹x‘ÆÎ,ìØÚŽ-45xödŠÂÐ8?ÈǘÏdå/Y|t½ß &LILð�J`è¡& ù-G³tã/ÿÿPK! Ñ�Ÿ¶'theme/theme/_rels/themeManager.xml.rels„�M Â0„÷‚wooÓº‘&݈ЭÔ„ä5 6?$Qìí ®,.‡a¾™i»—�Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£�Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!éÞ¿ÿ[Content_Types].xmlPK-!¥Ö§çÀ6 0_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!0ÝC)¨¤Ötheme/theme/theme1.xmlPK-! Ñ�Ÿ¶'² theme/theme/_rels/themeManager.xml.relsPK]­ Y "ÿÿÿÿXÀY ù �Y ð8ð@ñÿÿÿ€€€÷ð’ðð0ð( ð ððB ðS ð¿Ëÿ ?ð-239Ž“o€[ ÉÊ[ [ [ zûp>ë�ÿÿÿÿÿÿÿÿÿ´}ŽzÀí³ú‚ÿÿÿÿÿÿÿÿÿ„<„˜þÆ<^„<`„˜þo(.„ª„˜þƪ^„ª`„˜þo(()‚„z„LÿÆz^„z`„Lÿ.€„J „˜þÆJ ^„J `„˜þ.€„ „˜þÆ ^„ `„˜þ.‚„ê„LÿÆê^„ê`„Lÿ.€„º„˜þƺ^„º`„˜þ.€„Š„˜þÆŠ^„Š`„˜þ.‚„Z„LÿÆZ^„Z`„Lÿ. „Є˜þÆÐ^„Ð`„˜þOJQJo(·ð€„ „˜þÆ ^„ `„˜þOJQJ^Jo(o€ „p„˜þÆp^„p`„˜þOJQJo(§ð€ „@ „˜þÆ@ ^„@ `„˜þOJQJo(·ð€„„˜þÆ^„`„˜þOJQJ^Jo(o€ „à„˜þÆà^„à`„˜þOJQJo(§ð€ „°„˜þư^„°`„˜þOJQJo(·ð€„€„˜þÆ€^„€`„˜þOJQJ^Jo(o€ „P„˜þÆP^„P`„˜þOJQJo(§ð´}Žzzûpÿÿÿÿÿÿÿÿÿÿÿÿ         aå^À “BkwgH æJ&d° î=gu(,¥v뱓[!ú)"ƒZ%l.â3üg8…x;[=Q@B|B¿~HïCJqKLØyLw}MmOk,QEuW¥^]"2^H_×aƒ;aMVataèEc°Fe%'gQ=gy&jDzj\AlÍ9oø(tftv¥YxH y%z7g|4&}?7}v�sl…ÞŠ aŠ”=�w�Çv‘ ~•Þ(˜­u˜.œt9 Æa«í¬’j¯„+´‹·±M¹7RÃ.È”~ÌN$ÐhÔå-ÚmOÛé|Þ¦5àð$âËmçg;èÝKèûSêïdñz9ñ3?òÜBõ}%ùR9ý'dþgþY [ ÿ@€ÉÉÉÉY ˜@ÿÿUnknownÿÿÿÿÿÿÿÿÿÿÿÿ G�ÿ*àAxÀ ÿTimes New Roman5�€Symbol3.� ÿ*àCxÀ ÿArial7.�ÿáÿ¬@ ŸCalibriY� CG TimesTimes New Roman7�ÿàÿ@ŸCambria?=� ÿ*àCxÀ ÿCourier New;�€WingdingsA�ÿàÿ$BŸCambria Math"qˆðÐh€=ùfó&' ׂ �ׂ !ð  ´´��r0S S 3ƒðüýHX ðÿ$Päÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ° 2!xx  ÜÿÿRobertadr152  þÿà…ŸòùOh«‘+'³Ù0Xˆ�œ¨¸ÄØ èô   ,8@HPäRobert Normal.dotmadr15210Microsoft Office Word@vÝA@-¡mÌ@l  V”Ïׂ þÿÕÍÕœ.“—+,ù®0è hp|„Œ” œ¤¬´ ¼ ÉäS   Title þÿÿÿ !"#$%þÿÿÿ'()*+,-þÿÿÿ/012345þÿÿÿýÿÿÿ8þÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀFÓÀ¾V”Ï:€1TableÿÿÿÿÿÿÿÿK&WordDocumentÿÿÿÿÿÿÿÿ4"SummaryInformation(ÿÿÿÿ&DocumentSummaryInformation8ÿÿÿÿÿÿÿÿÿÿÿÿ.CompObjÿÿÿÿÿÿÿÿÿÿÿÿrÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF Microsoft Word 97-2003 Document MSWordDocWord.Document.8ô9²q